n,n-dimethylarginine has been researched along with ns 309 in 1 studies
| Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (ns 309) | Trials (ns 309) | Recent Studies (post-2010) (ns 309) |
|---|---|---|---|---|---|
| 2,216 | 228 | 1,221 | 56 | 1 | 30 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, L; Boedtkjer, E; Dalsgaard, T; Hughes, A; Kroigaard, C; Misfeldt, MW; Nielsen, G; Schjorring, O; Simonsen, U; Stankevicius, E | 1 |
1 other study(ies) available for n,n-dimethylarginine and ns 309
| Article | Year |
|---|---|
Opening of small and intermediate calcium-activated potassium channels induces relaxation mainly mediated by nitric-oxide release in large arteries and endothelium-derived hyperpolarizing factor in small arteries from rat.
Topics: Animals; Anthracenes; Apamin; Arginine; Biological Factors; Drug Evaluation, Preclinical; Human Umbilical Vein Endothelial Cells; Indoles; Male; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Synthase; Oximes; Potassium Channels, Calcium-Activated; Propane; Pyrazoles; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents | 2011 |